AAS
TNDM icon

Avantax Advisory Services’s Tandem Diabetes Care TNDM Stock Holding History

Avantax Advisory Services’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,589
Closed -$201K – 2326
2024
Q4 		$201K Sell
5,589
-917
-14% -$31K ﹤0.01% 2048
2024
Q3 		$276K Buy
6,506
+505
+8% +$21.4K ﹤0.01% 1820
2024
Q2 		$242K Buy
+6,001
New +$250K ﹤0.01% 1841
2020
Q4 		– Sell
-13,016
Closed -$1.48M – 1326
2020
Q3 		$1.48M Buy
+13,016
New +$1.37M 0.02% 423

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Avantax Advisory Services's TNDM Position: Q1 2025 in Review

Avantax Advisory Services sold out of Tandem Diabetes Care (TNDM) in Q1 2025, closing a stake of 5,589 shares — an estimated $201K sold.

Avantax Advisory Services first reported a position in TNDM in Q3 2020 and held it in 4 quarters. The position peaked at $1.48M in Q3 2020. 275 funds tracked by Wall St. Rank hold TNDM as of Q1 2025.

  • Avantax Advisory Services reported no remaining Tandem Diabetes Care position as of Q1 2025 after selling out during the quarter.
  • Avantax Advisory Services sold 5,589 Tandem Diabetes Care shares in Q1 2025, an estimated $201K.
  • Avantax Advisory Services first reported a position in Tandem Diabetes Care in Q3 2020 and held it in 4 quarters.
  • Avantax Advisory Services's Tandem Diabetes Care position peaked at $1.48M in Q3 2020.
  • 275 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2025.

Based on Avantax Advisory Services's 13F filing for Q1 2025, filed 6 May 2025.